Compile Data Set for Download or QSAR
Report error Found 570 Enz. Inhib. hit(s) with all data for entry = 8792
TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318453(US9624241, Example 1A | US9624241, Example 1B | US...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318453(US9624241, Example 1A | US9624241, Example 1B | US...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318457(7-(3,5-Dimethylisoxazol-4-yl)-1-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318457(7-(3,5-Dimethylisoxazol-4-yl)-1-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318458(7-(3,5-Dimethylisoxazol-4-yl)-5-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318458(7-(3,5-Dimethylisoxazol-4-yl)-5-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318459(4-[7-(3,5-Dimethylisoxazol-4-yl)-2-oxo-1,2,4,5-tet...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318459(4-[7-(3,5-Dimethylisoxazol-4-yl)-2-oxo-1,2,4,5-tet...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318460(7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-3-yl-4,5-d...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318460(7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-3-yl-4,5-d...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318461(7-(3,5-Dimethylisoxazol-4-yl)-4-(3-methoxyphenyl)-...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318461(7-(3,5-Dimethylisoxazol-4-yl)-4-(3-methoxyphenyl)-...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318462(7-(3,5-Dimethylisoxazol-4-yl)-4-(2-methoxyphenyl)-...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318462(7-(3,5-Dimethylisoxazol-4-yl)-4-(2-methoxyphenyl)-...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318463(7-(3,5-Dimethylisoxazol-4-yl)-4-(2,4-difluoropheny...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318463(7-(3,5-Dimethylisoxazol-4-yl)-4-(2,4-difluoropheny...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318464(7-(3,5-Dimethylisoxazol-4-yl)-2-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318464(7-(3,5-Dimethylisoxazol-4-yl)-2-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318465(7-(3,5-Dimethylisoxazol-4-yl)-1-(2-morpholin-4-yle...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318467(7-(3-Methyl-1H-pyrazol-4-yl)-4-phenyl-4,5-dihydroi...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318468(7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-d...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318468(7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-d...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318470(7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-d...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318470(7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-d...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318471(4-Cyclohexyl-7-(3,5-dimethylisoxazol-4-yl)-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318471(4-Cyclohexyl-7-(3,5-dimethylisoxazol-4-yl)-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM419916(US10464947, Example 18)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318473(7-(3,5-Dimethylisoxazol-4-yl)-4-(tetrahydrofuran-2...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318474(7-(3,5-Dimethylisoxazol-4-yl)-4-(1,3-thiazol-2-yl)...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318474(7-(3,5-Dimethylisoxazol-4-yl)-4-(1,3-thiazol-2-yl)...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318475(2-{2-[7-(3,5-Dimethylisoxazol-4-yl)-2-oxo-1,2,4,5-...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318475(2-{2-[7-(3,5-Dimethylisoxazol-4-yl)-2-oxo-1,2,4,5-...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318476(Ethyl 7-(3,5-dimethylisoxazol-4-yl)-2-oxo-4-phenyl...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318476(Ethyl 7-(3,5-dimethylisoxazol-4-yl)-2-oxo-4-phenyl...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318477(7-(3,5-Dimethylisoxazol-4-yl)-N-ethyl-2-oxo-4-phen...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318478(7-(3,5-Dimethylisoxazol-4-yl)-N-ethyl-2-oxo-4-phen...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318479(7-(3,5-Dimethylisoxazol-4-yl)-N-isopropyl-4-phenyl...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318479(7-(3,5-Dimethylisoxazol-4-yl)-N-isopropyl-4-phenyl...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318480(7-(3,5-Dimethylisoxazol-4-yl)-N-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318480(7-(3,5-Dimethylisoxazol-4-yl)-N-methyl-4-phenyl-4,...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318481(7-(3,5-Dimethylisoxazol-4-yl)-N-ethyl-4-phenyl-4,5...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318481(7-(3,5-Dimethylisoxazol-4-yl)-N-ethyl-4-phenyl-4,5...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318482(7-(3,5-Dimethylisoxazol-4-yl)-N,N-dimethyl-4-pheny...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318482(7-(3,5-Dimethylisoxazol-4-yl)-N,N-dimethyl-4-pheny...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318483(2-{[7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318483(2-{[7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318484(2-{[7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318484(2-{[7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318485(2-{[7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [342-460](Human)
Incyte Holdings

US Patent
LigandPNGBDBM318485(2-{[7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dih...)
Affinity DataIC50: 100nMAssay Description:BRD4-BD1 and BRD4-BD2 assays were conducted in white 384-well polystyrene plate in a final volume of 20 μL for BD1 and 40 μL for BD2. Inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 570 total ) | Next | Last >>
Jump to: